Outcomes of toxoplasmosis after allogeneic hematopoietic stem cell transplantation and the role of antimicrobial prophylaxis

Bone Marrow Transplant. 2024 May;59(5):699-704. doi: 10.1038/s41409-024-02238-x. Epub 2024 Feb 14.

¹ Department of Infectious Diseases, Infection Control, and Employee Health, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
² Department of Medicine- Division of Infectious Diseases, Louisiana State University Health Shreveport, Shreveport, LA, USA.
³ Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁴ OU Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Department of Medicine-Section of Hematology and Medical Oncology, Oklahoma City, OK, USA.
⁵ Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
⁶ Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA. SAhmed3@mdanderson.org.

^# Contributed equally.

No abstract available

Publication types